Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery - A randomized trial

被引:390
作者
Gandhi, Gunjan Y. [1 ]
Nuttall, Gregory A. [1 ]
Abel, Martin D. [1 ]
Mullany, Charles J. [1 ]
Schaff, Hartzell V. [1 ]
O'Brien, Peter C. [1 ]
Johnson, Matthew G. [1 ]
Williams, Arthur R. [1 ]
Cutshall, Susanne M. [1 ]
Mundy, Lisa M. [1 ]
Rizza, Robert A. [1 ]
McMahon, M. Molly [1 ]
机构
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
关键词
D O I
10.7326/0003-4819-146-4-200702200-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is not known whether rigorous intraoperative glycemic control reduces death and morbidity in cardiac surgery patients. Objective: To compare outcomes of intensive insulin therapy during cardiac surgery with those of conventional intraoperative glucose management. Design: A randomized, open-label, controlled trial with blinded end point assessment. Setting: Tertiary care center. Patients: Adults with and without diabetes who were undergoing on-pump cardiac surgery. Measurements: The primary outcome was a composite of death, sternal infections, prolonged ventilation, cardiac arrhythmias, stroke, and renal failure within 30 days after surgery. Secondary outcome measures were length of stay in the intensive care unit and hospital. Intervention: Patients were randomly assigned to receive continuous insulin infusion to maintain intraoperative glucose levels between 4.4 (80 mg/dL) and 5.6 mmol/L (100 mg1dQ (n = 199) or conventional treatment (n = 201). Patients in the conventional treatment group were not given insulin during surgery unless glucose levels were greater than 11.1 mmol/L (> 200 mg/dL). Both groups were treated with insulin infusion to maintain normoglycemia after surgery. Results: Mean glucose concentrations were statistically significantly lower in the intensive treatment group at the end of surgery (6.3 mmol/L [SD, 1.6] [114 mg/dL {SID, 29}] in the intensive treatment group vs. 8.7 mmol/L [SID, 2.3] [157 mg/dL [SID, 421] in the conventional treatment group; difference, -2.4 mmol/L [95% Cl, -2.8 to - 1.9 mmol/L] [-43 mg/dL {Cl, -50 to - 35 mg/dL}]). Eighty two of 185 patients (44%) in the intensive treatment group and 86 of 186 patients (46%) in the conventional treatment group had an event (risk ratio, 1.0 [Cl, 0.8 to 1.2]). More deaths (4 deaths vs. 0 deaths; P = 0.061) and strokes (8 strokes vs. 1 strokes; P = 0.020) occurred in the intensive treatment group. Length of stay in the intensive care unit (mean, 2 days [SID, 2] vs. 2 days [SID, 31; difference, 0 days [Cl, -1 to 1 days]) and in the hospital (mean, 8 days [SD, 4] vs. 8 days [SID, 5]; difference, 0 days [Cl, -1 to 0 days]) was similar for both groups. Limitations: This single-center study used a composite end point and could not examine whether outcomes differed by diabetes status. Conclusions: Intensive insulin therapy during cardiac surgery does not reduce perioperative death or morbidity. The increased incidence of death and stroke in the intensive treatment group raises concern about routine implementation of this intervention.
引用
收藏
页码:233 / 243
页数:11
相关论文
共 25 条
[1]   SHORT-TERM HYPERGLYCEMIA DEPRESSES IMMUNITY THROUGH NONENZYMATIC GLYCOSYLATION OF CIRCULATING IMMUNOGLOBULIN [J].
BLACK, CT ;
HENNESSEY, PJ ;
ANDRASSY, RJ .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1990, 30 (07) :830-833
[2]   Maintenance of normoglycemia during cardiac surgery [J].
Carvalho, G ;
Moore, A ;
Qizilbash, B ;
Lachapelle, K ;
Schricker, T .
ANESTHESIA AND ANALGESIA, 2004, 99 (02) :319-324
[3]   Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia [J].
Chaney, MA ;
Nikolov, MP ;
Blakeman, BP ;
Bakhos, M .
ANESTHESIA AND ANALGESIA, 1999, 89 (05) :1091-1095
[4]  
Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO
[5]  
2-V
[6]   Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery [J].
Doenst, T ;
Wijeysundera, D ;
Karkouti, K ;
Zechner, C ;
Maganti, M ;
Rao, V ;
Borger, MA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (04) :1144-1150
[7]   The STS National Database: Current changes and challenges for the new millennium [J].
Ferguson, TB ;
Dziuban, SW ;
Edwards, FH ;
Eiken, MC ;
Shroyer, ALW ;
Pairolero, PC ;
Anderson, RP ;
Grover, FL .
ANNALS OF THORACIC SURGERY, 2000, 69 (03) :680-691
[8]   Composite outcomes in randomized trials - Greater precision but with greater uncertainty? [J].
Freemantle, N ;
Calvert, M ;
Wood, J ;
Eastaugh, J ;
Griffin, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19) :2554-2559
[9]   Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting [J].
Furnary, AP ;
Gao, GQ ;
Grunkemeier, GL ;
Wu, YX ;
Zerr, KJ ;
Bookin, SO ;
Floten, HS ;
Starr, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (05) :1007-1021
[10]   Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients [J].
Gandhi, GY ;
Nuttall, GA ;
Abel, MD ;
Mullany, CJ ;
Schaff, HV ;
Williams, BA ;
Schrader, LM ;
Rizza, RA ;
McMahon, MM .
MAYO CLINIC PROCEEDINGS, 2005, 80 (07) :862-866